Peregrine Industries, Inc. (PGID)
USD 0.09
(0.0%)
USD 0.09
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -173.93 Thousand | 390.71 Thousand | -122.28 Thousand | -14.09 Thousand | -20.09 Thousand | 427.83 Thousand |
| Net Income | -394.08 Thousand | -99.69 Thousand | -140.46 Thousand | -14.09 Thousand | -20.09 Thousand | -15.96 Thousand |
| Depreciation & Amortization | 4564.00 | 65.75 Thousand | 103.29 Thousand | 102.27 Thousand | 104.77 Thousand | - |
| Deferred income taxes | - | - | - | -1.01 Million | -106.37 Thousand | - |
| Stock-based compensation | - | - | - | 388.25 Thousand | 1600.00 | - |
| Change in working capital | 5875.00 | -13.11 Thousand | 4031.00 | -78.18 Thousand | -1024.00 | 427.83 Thousand |
| Other non-cash items | 209.7 Thousand | 437.77 Thousand | -89.15 Thousand | 605.29 Thousand | 1024.00 | -411.87 Thousand |
| Investing Cash Flow | -11.56 Thousand | -18.72 Thousand | -48.69 Thousand | -20.23 Thousand | -10.79 Thousand | - |
| Investments in PPE | -11.56 Thousand | -18.72 Thousand | -48.69 Thousand | -20.23 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -11.56 Thousand | 613.9 Thousand | -34.69 Thousand | -20.23 Thousand | -10.79 Thousand | - |
| Financing Cash Flow | 10 Thousand | 106.7 Thousand | 159.98 Thousand | 14.09 Thousand | 20.09 Thousand | 3000.00 |
| Debt repayment | -149.00 | -50 Thousand | -79.98 Thousand | -82.7 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10 Thousand | 50 Thousand | 50 Thousand | 25 Thousand | - | 443.8 Thousand |
| Other Financing Activities | 149.00 | 106.7 Thousand | 189.96 Thousand | 71.8 Thousand | 20.09 Thousand | -440.8 Thousand |
| Accounts receivables | 4538.00 | 3766.00 | 8385.00 | -30.34 Thousand | -4457.00 | - |
| Accounts payables | -8518.00 | -15.16 Thousand | -6487.00 | -4661.00 | -1024.00 | - |
| Inventory | 773.00 | 80.00 | 1126.00 | 22.5 Thousand | -50.47 Thousand | - |
| Other working capital | 3207.00 | -1798.00 | 1007.00 | -65.68 Thousand | 54.93 Thousand | 427.83 Thousand |
| Cash at beginning of period | 572.97 Thousand | 94.28 Thousand | 105.28 Thousand | 3000.00 | 3000.00 | -427.83 Thousand |
| Cash at end of period | 397.46 Thousand | 572.97 Thousand | 94.28 Thousand | 3000.00 | 3000.00 | 3000.00 |
| Capital Expenditure | -11.56 Thousand | -18.72 Thousand | -48.69 Thousand | -20.23 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | -287.65 Thousand | 423.97 Thousand | - |
| Net cash flow / Change in cash | -175.5 Thousand | 478.69 Thousand | -11 Thousand | - | - | 430.83 Thousand |
| Free Cash Flow | -185.5 Thousand | 371.99 Thousand | -170.98 Thousand | -34.33 Thousand | -20.09 Thousand | 427.83 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -70.67 Thousand | -46.11 Thousand | -57.26 Thousand | -394.08 Thousand | -49.57 Thousand | -180.95 Thousand |
| Depreciation & Amortization | -7646.00 | 3077.00 | 4569.00 | 4564.00 | 2.00 | -1.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 31.99 Thousand | -7602.00 | -1207.00 | 5875.00 | -5496.00 | 1475.00 |
| Other non-cash items | -18.37 Thousand | 5317.00 | 7021.00 | 209.7 Thousand | 13.63 Thousand | 144.98 Thousand |
| Investing Cash Flow | -5370.00 | -1100.00 | -500.00 | -11.56 Thousand | 11.56 Thousand | -4753.00 |
| Investments in PPE | -5370.00 | -1100.00 | -500.00 | -11.56 Thousand | 11.56 Thousand | -4753.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -5370.00 | -1100.00 | -500.00 | -11.56 Thousand | - | -4753.00 |
| Financing Cash Flow | - | - | -4680.00 | 10 Thousand | -11.56 Thousand | 261.00 |
| Debt repayment | - | - | -4680.00 | -149.00 | -112.00 | -261.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 10 Thousand | - | - |
| Other Financing Activities | - | - | - | 149.00 | -11.45 Thousand | 522.00 |
| Accounts receivables | 15.2 Thousand | 1708.00 | 1200.00 | 4538.00 | -123.00 | 1392.00 |
| Accounts payables | 4328.00 | -1109.00 | 615.00 | -8518.00 | -23.18 Thousand | 937.00 |
| Inventory | 194.00 | 238.00 | 302.00 | 773.00 | 583.00 | -743.00 |
| Other working capital | 12.26 Thousand | -8439.00 | -2117.00 | 3207.00 | 17.22 Thousand | -111.00 |
| Cash at beginning of period | 299.99 Thousand | 350.62 Thousand | 397.46 Thousand | 572.97 Thousand | 438.89 Thousand | 478.14 Thousand |
| Cash at end of period | 258.13 Thousand | 299.99 Thousand | 350.62 Thousand | 397.46 Thousand | 397.46 Thousand | 438.89 Thousand |
| Capital Expenditure | -5370.00 | -1100.00 | -500.00 | -11.56 Thousand | 11.56 Thousand | -4753.00 |
| Effect of forex changes on cash | - | - | 12.24 Thousand | - | -1.00 | -261.00 |
| Net cash flow / Change in cash | -41.85 Thousand | -50.63 Thousand | -46.83 Thousand | -175.5 Thousand | -41.43 Thousand | -39.24 Thousand |
| Free Cash Flow | -42.69 Thousand | -51.74 Thousand | -54.39 Thousand | -185.5 Thousand | -29.86 Thousand | -39.24 Thousand |
TBN
RECV3
688533
SUNPHARMA
CCR
HPBL